Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Brainsway ( (BWAY) ) has issued an update.
On September 16, 2025, BrainsWay Ltd. announced that it received FDA clearance for an accelerated Deep TMS protocol for treating major depressive disorder (MDD), including patients with comorbid anxiety symptoms. This new protocol, which reduces treatment time significantly, is now available in the U.S., potentially enhancing patient access and treatment efficiency. Clinical trials demonstrated that the accelerated protocol is comparable to the standard Deep TMS protocol in terms of depression score improvement, response, and remission rates, with no severe adverse events reported. This development marks a significant advancement in the treatment of MDD, addressing the need for more accessible and effective therapies for patients who do not respond to traditional treatments.
The most recent analyst rating on (BWAY) stock is a Buy with a $19.00 price target. To see the full list of analyst forecasts on Brainsway stock, see the BWAY Stock Forecast page.
Spark’s Take on BWAY Stock
According to Spark, TipRanks’ AI Analyst, BWAY is a Outperform.
Brainsway’s overall stock score is driven by its strong financial performance and positive earnings call, highlighting significant revenue growth and strategic investments. However, the high valuation and technical indicators suggesting overbought conditions temper the score.
To see Spark’s full report on BWAY stock, click here.
More about Brainsway
BrainsWay Ltd. is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders. The company specializes in Deep Transcranial Magnetic Stimulation (Deep TMS) technology, which is used to treat major depressive disorder, obsessive-compulsive disorder, and smoking addiction. Founded in 2003, BrainsWay operates in the United States and Israel and is committed to increasing global awareness and access to Deep TMS.
Average Trading Volume: 64,102
Technical Sentiment Signal: Buy
Current Market Cap: $287.4M
Learn more about BWAY stock on TipRanks’ Stock Analysis page.